welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Capricor places Duchenne drug trial on hold

Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy, a muscle-wasting disorder.

The hold was due to an ongoing safety review following severe allergic reaction that occurred during the trial, the company said in a filing.

Capricor Places Duchenne Drug Trial On Hold